Comparison Between Diode Laser and Bleomycin in Treatment of Hemangioma
NCT ID: NCT06510829
Last Updated: 2024-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
30 participants
OBSERVATIONAL
2024-09-01
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Clinically based on Change in the Size and Color of Hemangioma.
* Ultrasonography considering Vascularity ,Echogenicity , Height , and Morphology .
* Comparison of Complications associated with Bleomycin and Diode Laser.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Intralesional Bleomycin Alone and in Combination With Dexamethasone in Infantile Haemangiomas
NCT06080724
Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma
NCT06943703
Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients
NCT06437158
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
NCT01873131
Retrospective Cohort Study on the Impact of PDL Treatment History on the Efficacy of HMME-PDT in Treating PWS Children
NCT06875492
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Group will be treated with intralesional bleomycin injection
No interventions assigned to this group
Group b
Group will be treated with application of diode laser
Diode laser
Application of laser waves on the lesion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diode laser
Application of laser waves on the lesion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non Complicated Infantile Hemangioma
Exclusion Criteria
* Complicated Infantile Hemangioma
3 Months
12 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kerolos Fayez
Kerolos Fayez Youakeem
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Diode laser hemangioma
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.